Bilypsa Tablet
Prescription Required
Product introduction
Bilypsa Tablet is a medicine used in the treatment of Noncirrhotic Non-Alcoholic Steatohepatitis, Non-alcoholic Fatty Liver Disease (NAFLD) with comorbidities (like obesity, Type 2 Diabetes Mellitus, Dyslipidemia or Metabolic Syndrome), and high cholesterol in diabetes (diabetic dyslipidemia).
Bilypsa Tablet has beneficial effects in controlling high cholesterol, triglycerides and sugar levels in diabetic patients. It should be taken before the first meal of the day. Use this medicine along with a proper diet and exercise for best results.
Bilypsa Tablet has beneficial effects in controlling high cholesterol, triglycerides and sugar levels in diabetic patients. It should be taken before the first meal of the day. Use this medicine along with a proper diet and exercise for best results.
Uses of Bilypsa Tablet
- Treatment of Noncirrhotic Non-Alcoholic Steatohepatitis
- Treatment of Non-alcoholic fatty liver disease
- Treatment of Diabetic dyslipidemia (high cholesterol in diabetes)
Benefits of Bilypsa Tablet
In Treatment of Noncirrhotic Non-Alcoholic Steatohepatitis
Noncirrhotic non-alcoholic steatohepatitis (NASH) is liver inflammation and damage caused by excess fat in the liver. Because of the damage, the liver doesn't work as well as it should. Bilypsa Tablet reduces fat deposition thereby improving its overall functioning.
In Treatment of Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease is a condition in which there is an increased buildup of fat in the liver. It affects people who drink little to no alcohol. Bilypsa Tablet protects the liver and reduces the risk of liver failure.
In Treatment of Diabetic dyslipidemia (high cholesterol in diabetes)
Bilypsa Tablet helps in the management of high cholesterol, as well as blood sugar levels in people with type 2 diabetes. It is mainly used in people whose cholesterol levels are not controlled by statin therapy alone. By controlling high cholesterol levels, Bilypsa Tablet helps reduce the risk of heart diseases.
Side effects of Bilypsa Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Bilypsa
- Flatulence
- Indigestion
- Abdominal distension
- Weakness
- Increased body temperature
How to use Bilypsa Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Bilypsa Tablet may be taken with or without food, but it is better to take it at a fixed time.
How Bilypsa Tablet works
Bilypsa Tablet contains Saroglitazar, a dual action peroxisome proliferator-activated receptor (PPAR) inhibitor that aids in the management of high cholesterol, especially triglycerides, as well as blood sugar levels in people with type 2 diabetes. It acts by a unique mechanism in which it reduces the synthesis and secretion of triglycerides (a type of lipid or cholesterol in blood). It also improves insulin sensitivity of the body for better utilization of the existing insulin and hence lowers the blood sugar levels.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Bilypsa Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Bilypsa Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CAUTION
Bilypsa Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Driving
SAFE
Bilypsa Tablet does not usually affect your ability to drive.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Bilypsa Tablet in patients with kidney disease. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Bilypsa Tablet in patients with liver disease. Please consult your doctor.
What if you forget to take Bilypsa Tablet?
If you miss a dose, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and take it at the next scheduled time. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Bilypsa Tablet
₹44.18/Tablet
Lipaglyn Tablet
Zydus Cadila
₹36.56/tablet
10% cheaper
Quick tips
- It is better to take Bilypsa Tablet after a meal or with a snack to avoid stomach problems.
- Your doctor may check your liver function before starting the treatment and regularly thereafter.
- It is important that you keep your regular appointments with your doctor so your condition can be monitored.
- Lifestyle changes like a low-fat and sugar diet, exercise, losing weight, not smoking, and cutting down on the amount of alcohol you normally drink may help this medication work better.
Fact Box
Chemical Class
Phenylpyrrole Derivative
Habit Forming
No
Therapeutic Class
ANTI DIABETIC
Action Class
PPAR alpha / gamma agonist
Patient concerns
FAQs
Who should not take Bilypsa Tablet?
Bilypsa Tablet should not be taken by people who are allergic to Bilypsa Tablet or any of its ingredients. If you are not sure, please consult your doctor.
Is there a chance of weight gain with Bilypsa Tablet?
It has been observed from clinical research conducted on Bilypsa Tablet that there is no significant risk of weight gain in patients taking Bilypsa Tablet. However, if a patient experiences a rapid increase in weight, any other difficulty, or fluid accumulation in the body then it should be immediately informed to the doctor for further assessment or change of therapy.
Is Bilypsa Tablet is helpful in increasing good cholesterol?
Yes, it has been found that Bilypsa Tablet helps improve the good cholesterol or HDL-C and at the same time helps reduce the bad cholesterol like LDL, triglycerides etc. Though the effectiveness of this medicine varies from patient to patient still it has been found to be effective in controlling the high triglyceride levels in the blood. Consult your doctor before you start taking this medication.
What other lifestyle changes should I make to manage nonalcoholic steatohepatitis (NASH)
Lifestyle changes play a major role in managing nonalcoholic steatohepatitis (NASH). A healthy body weight helps you manage this condition very effectively. Avoid taking excess salt in your diet and find ways to reduce or manage stress in your life as it increases body weight too. Practice yoga or meditation or take up a hobby. Ensure that you have a sound sleep every night as this also helps to reduce stress levels. Stop smoking and alcohol consumption. Exercise regularly and take a balanced diet that includes whole grains, fresh fruits, vegetables and fat-free products. Consult your doctor if you need any further guidance to get the maximum benefit of Bilypsa Tablet and to keep yourself healthy.
Can I take Bilypsa Tablet in pregnancy?
There is no clarity on the use of Bilypsa Tablet in pregnancy and it may be unsafe to take it in pregnancy. However, if you are pregnant or planning to conceive, consult your doctor before taking Bilypsa Tablet. You may take it only if prescribed by your doctor.
Is it safe for lactating mothers to take Bilypsa Tablet?
No, it is not safe for lactating mothers to take Bilypsa Tablet because there is no evidence of its safety for usage during breastfeeding. The other reason for not using this medicine is that it is not known whether Bilypsa Tablet gets excreted via breast milk. Consult your doctor before taking this medicine if you are breastfeeding to make sure there is no harm to your baby.
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Rajesh NA, Drishya L, Ambati MMR, Narayanan AL, Alex M, R KK, Abraham JJ, Vijayakumar TM. Safety and Efficacy of Saroglitazar in Nonalcoholic Fatty Liver Patients With Diabetic Dyslipidemia-A Prospective, Interventional, Pilot Study. J Clin Exp Hepatol. 2022 Jan-Feb;12(1):61-67. [Accessed 06 Aug. 2023] (online) Available from:
Marketer details
Name: Zydus Cadila
Address: Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.
Country of origin: India
Expires on or after: February, 2025
A licensed vendor partner from your nearest location will deliver Bilypsa Tablet. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.
Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India
Expires on or after: February, 2025
A licensed vendor partner from your nearest location will deliver Bilypsa Tablet. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.
In case of any issues, contact us
Email ID: [email protected]Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India
Lab tests offered by us
Related/Popular tests
₹384.37₹441.8Get 13% OFF
₹375.53+ free shipping with
Inclusive of all taxes
Get this discount by applying coupon TESTING_REPEAT on the cart. Max. coupon discount is ₹500. T&C apply.
1 Strip
10.0 tablets in 1 strip
Variants (2)